Related Experiment Videos
Assessing disease activity in the systemic vasculitides
1Consultant Rheumatologist and Part Time Senior Lecturer, Rheumatology Department, University of Edinburgh, Edinburgh, United Kingdom. raashid.luqmani@ed.ac.uk
Current Opinion in Rheumatology
|January 16, 2002
Summary
Systemic vasculitis management requires accurate assessment tools. These clinical tools are effective for monitoring disease activity and aiding treatment in patients and clinical trials.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Improved survival in systemic vasculitides highlights the need to address long-term morbidity and relapse.
- Understanding antineutrophil cytoplasmic antibody-related vasculitis pathophysiology has led to better diagnostic assays.
Purpose of the Study:
- To review clinical assessment tools for systemic vasculitis.
- To emphasize the importance of accurate disease activity and damage measurement.
Main Methods:
- Review of existing clinical assessment tools for systemic vasculitis.
- Discussion of advancements in serologic assessment based on pathophysiology.
Main Results:
- Clinical assessment tools are practical and effective for measuring disease activity and damage.
- Improved serologic assays may offer more precise disease assessment.
Conclusions:
- Clinical assessment tools are vital for managing individual systemic vasculitis patients.
- These tools play a crucial role in the design and execution of clinical trials for systemic vasculitis.